Professional Documents
Culture Documents
and rest of the expenditure will be met from Cooperative Education fund. At present NCUI is
running 44 projects spread over 22 States/UTs. During the year 2012-13, an amount of Rs.
358.50 lakhs was released as grants-in-aid to NCUI including Rs. 30 lakh for the NE regions.
The NCUI organized 27,698 events and imparted education to 4.63 lakh persons, including 66
training programmes for 1998 persons.
12.5 The Cooperative Training Programmes are being conducted by the National Council for
Cooperative Training (NCCT) through its 5 Regional Institutes of Cooperative Management,
14 Institutes of Cooperative Management, located in different States and the Vaikunth Mehta
National Institute of Cooperative Management, Pune. The NCCT had also been receiving 100
percent financial assistance for conducting cooperative training programmes up to 11th Five
Year Plan. However, from 12th five year plan onwards it has been proposed that NCCT will
meet its requirement by utilizing interest earnings of corpus funds created during the 10th Plan
by equal contribution of Rs.100 crores by the GOI and cooperative movement. The Council
provides academic support to Junior Cooperative Training Centers (JCTC) in the country
which is run by State Cooperative Unions/States Governments. There is no change in pattern
of financial assistance as far as JCTC and VAMNICOM is concerned. During the year 201213, DAC released Rs. 570.00 lakhs to NCCT for the VAMNICOM component.
12.6 Cooperative Education and Training Activities in the North Eastern Region: The
Government of India is implementing a special scheme for Intensification of cooperative
education in cooperatively under-developed States including the North-Eastern Region through
NCUI. NCUI has established 8 field projects, namely, Aizwal (Mizoram), Thobal & Imphal
(Manipur), Mangalwaria (Sikkim), Shillong (Meghalaya), Kohima (Nagaland), Morigaon and
Jorhat (Assam) in the North-Eastern Region.
12.7 Women Development Activities: With the overall objective of bringing women in the
cooperative fold from grass root levels by informal approach and to revitalize and develop
women participation in group activities and to improve the socio-economic conditions of
women of selected blocks, NCUI is now running 4 exclusive women development projects
located at Shimoga (Karnataka), Berhampur (Odisha), Imphal (Manipur) and Bhopal (MP)
under the Special Scheme of intensification of Cooperative Education in the cooperatively
under-developed states. Besides, each field project has got a special women development
component. Under this, women are organized into self-help groups and help them to develop
thrift habits. Women are also given training to undertake income-generating activities with the
help of their own resources or by borrowing from cooperatives.
The projects personnel help them in marketing their produce in the local market by organizing
fair/exhibitions. During the year 2012-13, a total number of 31,358 women were benefited by
the education programmes organized by the cooperative education field projects in NE states.
12.8 Assistance to NCDC Programmmes for Development of Cooperatives: The
Government of India implements its cooperative development programmes through National
Cooperative Development Corporation (NCDC). The programmes/schemes being
implemented through NCDC are (i) Integrated Cooperative Development Projects in selected
districts, (ii) assistance to cooperative marketing, processing and storage etc., programmes in
cooperatively under-developed/least developed States/Union Territories and (iii) share capital
participation in growers/weavers cooperative spinning mills under the restructured central
sector scheme. It has been decided that under this scheme, subsidy component will be provided
by Government of India and the loan component will be arranged by NCDC through its own
sources.
12.9 NCDC is a non-equity based development financing institution created exclusively for the
cooperative sector with the objective of planning and promoting programmes for production,
processing, marketing, storage, export and import of agricultural produce, food stuff and
certain notified commodities and services on cooperative principles. With amendment of
NCDC Act in 2002, scope of activities of the Corporation has been widened to cover livestock,
cottage and village industries, handicrafts, rural crafts and certain notified services besides
enabling NCDC to lend directly to cooperative societies on furnishing security to the
satisfaction of the Corporation. With notification of additional services like tourism,
hospitality, transport, electricity & power, rural housing, healthcare, hospitals and education
cooperatives, the scope of NCDC funding has been further broadened. The Central
Government has however prescribed an overall ceiling of twenty five percent (25%) of annual
budget of NCDC for financing all activities under notified services so that focus of NCDC
continues on financing of cooperatives in agriculture & allied sector. The rates of interest on
NCDC loans ranged between 10.40% and 13.00% during the year. In 2013-14, an assistance
of Rs 5,267.04 crore has been disbursed by the NCDC against approved outlay of Rs. 4,500.00
crore.
12.10 Cooperative Spinning Mills: In order to improve economic condition of the cotton
growers as well as handloom & power loom weavers and to consolidate the gains achieved so
far, the Department, through NCDC, continued to provide financial assistance to the spinning
mills & ginning and pressing units in the cooperative sector. During the year 2013-14, NCDC
released an overall amount of Rs. 83.23 crore, including Rs 64.39 crore under Restructured
Central Sector Scheme. NCDC is implementing Restructured Central Sector Scheme of DAC
for share capital participation in Growers/Weavers Cooperative Spinning Mills. Term loans
are met out of funds of the Corporation and subsidy is provided by DAC under this scheme.
12.11 Cooperative Storage and Cold Storage: The Department of Agriculture and
Cooperation (DAC), through NCDC, has been making systematic and sustained efforts to assist
cooperatives in creating additional storage capacity aimed at facilitating expanded operations
of cooperative marketing of agriculture produce, distribution of inputs and sale of consumer
articles. Storage capacity assisted by NCDC has increased from 11 lakh MT to 159.96 lakh MT
as on 31.3.2014. During the year 2013-14, financial assistance of Rs. 46.66 crore (Rs 33.80
crore loan + Rs. 12.86 crore subsidy) has been released and Rs 98.48 crore (Rs 67.29 crore
loan + Rs 31.19 crore subsidy) has been sanctioned for the storage programme under Central
Sector Scheme of DAC.
12.12 NCDC provides financial assistance to the extent of 90% of the block cost to the State
Governments for setting up / modernization / expansion / rehabilitation of cold storages and
Ice plants by cooperatives. In case of direct funding, assistance to the extent of 75% is provided.
NCDC has also dovetailed its cold storage programme with National Horticulture Board
(NHB). In such cases quantum of assistance provided by NCDC is reduced by the subsidy
available under the Capital Investment Scheme (CIS) of NHB. The scheme provides enhanced
back-ended subsidy @ 40% of the project cost for general category and 55% in case of hilly
and scheduled areas for maximum storage capacity upto 5,000 MT per project at normative
cost @ Rs 6000 / 7000 / 8000 per MT as per prescribed standards under the scheme. During
the financial year 2013-14, assistance of Rs 2.30 crore has been sanctioned to one cold storage
project at Mahua, Bihar and Rs 3.89 crore has been released to such projects including spillover
assistance.
12.13 Integrated Cooperative Development Projects: NCDC is implementing Integrated
Cooperative Development Projects (ICDP) Scheme in selected districts in the rural areas.
During the year 2013-14, 19 projects in the States of Jharkhand (3), Arunanchal Pradesh (1),
Haryana (1) Kerala (1), Himachal Pradesh(3), Madhya Pradesh (2) and Uttar Pradesh (8) worth
Rs 421.99 crore have been sanctioned involving NCDCs share of assistance of Rs 405.70 crore
(Rs 321.20 crore as loan and Rs 84.50 crore as subsidy). During the same period, NCDC has
released loan assistance of Rs. 262.64 crore and Subsidy of Rs 39.54 crore totaling to Rs 302.18
crore for ICDP. The subsidy of Rs 39.54 crore includes Rs 12.16 crore towards expenditure on
Project Implementation Team.
12.14 Cooperatives in under developed States: The process of economic development in the
country brought to light certain regional disparities and imbalances in some parts due to
inherent factors like topography, agro-climatic conditions and poor infrastructure. During
formulation of the Fifth Five Year Plan, limitation of this approach came to force and as a
consequence, the concept of cooperatively under-developed States evolved to ensure balanced
regional development. The categorization of States for funding by NCDC was reviewed by the
Planning Commission in November, 2004. Accordingly, Andhra Pradesh, Uttar Pradesh,
Madhya Pradesh and Goa were also placed under the category of cooperatively under
developed states. Similarly Jharkhand, Bihar and Jammu & Kashmir were classified as
cooperatively least developed States, in addition to the existing States. Now ten States and two
UTs., have been categorized as cooperatively under-developed and 11 States as leastdeveloped. During the year 2012-13, financial assistance of Rs 2461.14 crore has been
disbursed by the NCDC to cooperatives in cooperatively least/under-developed states/UTs.,
under its various schemes. During the year 2013-14, an amount of Rs.3,126.23 crore has been
provided for cooperatives in cooperatively least/under-developed states/UTs., under its various
schemes.
12.15 Strengthening of National-level Cooperative Federations and Multi State Cooperative
Societies (MSCS): The objective of the scheme is to assist the National Level Federations and
Multi State Cooperative Societies which are undertaking promotional and research activities,
bringing about improvement in infrastructural facilities and also to assist in building up their
equity base for betterment of the cooperative movement and improving the cooperative
activities in the rural areas of country.
12.16 Development of Women Cooperatives: NCDC encourages women cooperatives to
avail assistance under its various schemes. A large number of women members are engaged &
involved in cooperatives dealing with fruits & vegetables, ICDP, sugarcane processing,
consumer stores, handloom, power loom, spinning and services etc. activities. Upton
31.03.2014 the NCDC has cumulatively sanctioned and released financial assistance of Rs.
182.58 Crore and Rs 89.93 crore respectively for the development of cooperative societies
exclusively organized by women. This included foodgrain processing, plantation crops, oilseed
processing, fisheries, Integrated Cooperative Development Projects (ICDPs), spinning mills
handloom and powerloom weaving etc. During 2013-14, NCDC has sanctioned Rs 42.07 crore
for women cooperatives under ICDP Rs.12.40 crore), fisheries (Rs 4.42 crore), and power loom
(Rs 25.25 crore), programmes.
Providing the reservation of one seat for the Scheduled Castes or the Scheduled Tribes
and two seats for women on the board of every cooperative society, which have
individuals as members from such categories.
Providing for offences relating to-operative societies and penalties in respect of such
offences.
12.20 Amending the State Cooperative Societies Acts in tune with the provisions of the above
amendments in the Constitution will not only ensure autonomous and democratic functioning
of the cooperatives, but also ensure accountability of management to the members & other
stakeholders and also enhance public faith in these institutions. The Constitutional amendment
provides for a maximum period of one year from the date of its commencement to amend the
state laws relating to cooperative societies, if required, to make them consistent with the
provisions of the amendment. So far 15 States, viz. Arunachal Pradesh, Assam, Bihar,
Chhattisgarh, Gujarat, Haryana, Karnataka, Kerala , Madhya Pradesh, Mizoram, Odisha,
Rajasthan, Tripura, Uttar Pradesh and West Bengal have amended their State Cooperative
Societies Acts in consonance with the constitution(97th Amendment) Act, 2011 through the
legislative process; while two States viz. Maharashtra and Tamil Nadu have done so by issuing
ordinances. However, in the meantime certain provisions of the Constitution (97th
Amendment) Act, 2011 have been struck down by the Honble High Court of Gujarat at
Ahmedabad vide order dated 22.4.2013 in WP (PIL) No.166 of 2012. The union of India has
filed SLP No. 25266-25267 on 12.7.2013 before the Honble Supreme Court against the
aforesaid order.
12.21 Amendment to the Multi-State Co-operative Societies Act, 2002: The MSCS
(Amendment) Bill, 2010 was introduced in Lok Sabha on 15.11.2010. The proposed
amendment intends to strengthen the Cooperatives by making them more member-driven and
professional. Bill was referred to Standing Committee on Agriculture for examination and
report. The report of Standing Committee on Agriculture was presented on 20.12.2012 and the
same is under consideration of the Department.
12.22 Helping farmers in getting remunerative price for their produce through NAFED:
The Department of Agriculture & Cooperation is implementing Price Support Scheme (PSS)
for procurement of oilseeds and pulses through NAFED, NCCF, CWC and SFAC at the
Minimum Support Price (MSP) declared by the Govt. The Department is also implementing
Market Intervention Scheme (MIS) for horticultural and agricultural commodities generally
perishable in nature and not covered under Price Support Scheme, thus, helping the farmers in
getting remunerative price for their produce.
12.23 Price Support Scheme (PSS): The Department of Agriculture & Cooperation
implements the PSS for procurement of oil seeds and pulses through National Agricultural
Cooperative Marketing Federation of India Ltd. (NAFED) and Small Farmers Agri-Business
Consortium (SFAC) which are Central nodal agencies, at the Minimum Support Price (MSP)
declared by the government. NAFED is the central nodal agency for procurement of cotton
also under PSS. Central agencies undertake procurement of oil seeds, pulses and cotton under
the PSS as and when prices fall below the MSP. Procurement under PSS is continued till prices
stabilize at or above the MSP. Losses, if any, incurred by central agency in undertaking PSS
operations are reimbursed by the central government. Profit, if any, earned in undertaking PSS
operations is credited to the Central Government.
12.24 Achievement under Price Support Scheme (PSS): During the Milling Copra 2013, the
prices of Milling Copra ruled below respective MSP fixed for the relevant marketing season.
NAFED procured Milling Copra during the Milling Copra 2013 as per the details given below:S. No.
1.0
2.0
3.0
4.0
5.0
State
Quantity in MTs
A & N Islands
Andhra Pradesh
Kerala
Lakshadweep
Tamil Nadu
3,300
1
41
538
551
1,732.50
0.53
21.53
282.45
289.28
12.25 Further, a quantity of 29,535 MTs of Ball Copra at the MSP of Rs. 5,500 per quintal
valuing Rs. 16,244.25 lakhs were also procured. A quantity of 4,384 MTs of sunflower seed
valuing Rs. 1,622.08 lakhs in Odisha, Karnataka and Andhra Pradesh were procured. Further,
groundnuts under PSS were also procured as per the details given below:
Quantity in MTs
Ex-go down value (Rs. in lakhs)
State
Odisha
830
307.10
Gujarat
1,07,203
42,881.20
Rajasthan
1,89,767
75,906.80
Uttar
7,347
2,938.80
Pradesh
8,819
3,527.60
5.0 Karnataka
61
24.40
6.0 Maharashtra
30,190
12,076.00
7.0 Andhra
Pradesh
S. No.
1.0
2.0
3.0
4.0
12.26 During Kharif 2012-13 and 2013-14, urad, tur and gram were also procured as per the
details given below: S. No.
1.
2.
3.
4.
5.
6.
7.
8.
9.
State
Maharashtra
Andhra Pradesh
Uttar Pradesh
Rajasthan
Madhya Pradesh
Karnataka
Gujarat
West Bengal
Jharkhand
Urad
Quantity in MTs
35,462.00
7,963.54
16,930.25
8,409.47
3,285.89
9,871.90
442.74
2,022.64
103.57
Tur
S. No.
1.
State
Maharashtra
Quantity in MTs
32,536.00
2.
3.
Andhra Pradesh
Madhya Pradesh
28,911.83
66.00
12,119.48
25.41
Gram
S. No.
1.
2.
3.
State
Maharashtra
Andhra Pradesh
Karnataka
Quantity in MTs
4,932
24,388
5,430
12.27 NAFED also procured cotton under PSS as per the details given below:S.
No.
1.0
State
Variety
Maharashtra
2.0
Andhra
Pradesh
Bunny
H-4/H-6
Bunny
H-4/H-6
Quantity in
MTs
1,203.20
16.20
1,80,290.95
-
12.28 Market Intervention Scheme (MIS): The Department of Agriculture & Cooperation
implements the Market Intervention Scheme (MIS) for procurement of horticultural
commodities which are perishable in nature and are not covered under the Price Support
Scheme. The objective of intervention is to protect the growers of these commodities from
making distress sale in the event of a bumper crop during the peak arrival period when the
prices tend to fall below economic levels and cost of production. The condition is that there
should be either at least a 10 percent increase in production or a 10 percent decrease in the
ruling market prices over the previous normal year. The Market Intervention Scheme (MIS) is
implemented at the request of a state / UT government which is ready to bear 50 percent of the
loss (25 percent in case of North-Eastern States), if any, incurred on its implementation. The
extent of total amount of loss to be shared on a 50:50 basis between the central government
and the state government is restricted to 25 percent of the total procurement value which
includes cost of the commodity procured plus permitted overhead expenses. Under the Scheme,
in accordance with MIS guidelines, a pre-determined quantity at the fixed Market Intervention
Price (MIP) is procured by NAFED as the Central agency and the agencies designated by the
state government for a fixed period or till the prices are stabilized above the MIP whichever is
earlier. The area of operation is restricted to the concerned state only. The details of MIS
implemented during the year 2012-13 and 2013-14 as on 31.03.2014 are as below:
S.
No.
1)
1
2
3
4
5
6
7
8
9
Year
Commodity
2)
2012-13
20.03.2012 to 20.05.2012
2012-13
25.05.2012 to 25.06.2012
2012-13
01.06.2012 to 30.06.2012
2012-13
01.12.2012 to 31.12.2012
2012-13
01.01.2013 to 31.03.2013
2012-13
07.03.2013 to 07.04.2013
2013-14
01.08.2013 to 21.10.2013
2013-14
01.08.2013 to 31.08.2013
2013-14
20.02.2014 to 20.03.2014
3)
Turmeric
MIP (Rs.
Per MTs)
4)
40,000/-
Chilly
41,000
Turmeric
40,000/-
5)
Andhra
Pradesh
Andhra
Pradesh
Tamil Nadu
Iskut
(Choyate)
Oil Palm
FFB
Potato
5,600
Mizoram
4,000
5,720/-
90,000
C-grade
Apple
Pineapple
6,500/-
Andhra
Pradesh
Uttar
Pradesh
Himachal
Pradesh
Nagaland
Potato
3,750/-
Uttar
Pradesh
1,00,000
3,580/-
8,500/-
State
Sanctioned Qty.
(in MTs.)
6)
54,000
52,000
35,000
1,00,000
27,000
12,675
export agency. This whole scheme of sugar controls is not in the interest of the industry or the
economy. The government has announced its intention to review this policy regime with the
objective of making sugar industry globally competitive and generating export surplus while
insuring adequate supplies for domestic consumption as a part of restricting sugar industry
beginning was made when price and distribution controls on molasses were abolished in Jane
1993 the government has also announced number of incentives to encourage sugar mills to
maximize sugar production.
10) The Questions of minimum economic size:
The minimum economics size as it exists in India is 2500 tons of came crushed per day (tpcd)
this is much less than the minimum economic size in other countries for instance in Thailand
the average plant size is of 10000 tpcd against the average of 1400 tpcd in these country
according to some experts the sheer size makes us loss out in the economics of scale also the
small MES makes efficient use of by-products impossible.
11) Old Machinery:
Like jute and cotton textiles some sugar factory also requires replacement of old machinery
and modernization of production technique. The need is particularly great for the sugar
factories located in U.P and Bihar.
12) Competition From cheaper Imports:
Stiff competition from cheap imports is causing problem for the sugar industry sugar import in
recent years have been due to ample global availability and heavy export subsidies in several
countries including Pakistan, Brazil, and the European union. The international sugar prices
tumbled down so imported sugar is cheaper than domestic sugar.
13) Low sugar Recovery:
The Sugar recovery from the canes as also the yield of cane crop has been stagnant for a long
time for want of any major breakthrough in reading better verities of sugar cane. The average
recovery (Extraction rate for the Indian sugar mills is just 9.5 to 10 percent against 13 to 14
percent in some other producing countries
14) Overall observation:
The main reason for sickness in the sugar industry as many as 70 mills are lying closed are: the
practice of state advise price (SAP) for sugar cane low realization from the sale of molasses
fluctuations in sugar production non availability of adequate cane and the uneconomic size of
the mills and their out date machinery and mismanagement. This implies that adequate relief
and concessions would be required from state government banks and financial instructions for
the revival of sick and closed sugar mills.
15. Cane Price:
A High level Committee to be appointed by the Government for determining cane price which
should be linked to sugar price through some transparent formula based methodology. The
price so decided should also take into consideration inter-crop parity to avoid cyclicality in
sugarcane production.
16. Release Mechanism:
Sugar is sold by sugar factories on the basis of release orders issued monthly by the Sugar
Directorate, Government of India. Release mechanism should be discontinued in order to have
better cash management and timely payment to the farmers. Price discovery should be done
through a transparent Forwards and Futures market.
17. Levy Sugar Obligation:
The Government declares a certain proportion of sugar production as Levy sugar (at present
10% of total production) to be sold under Public Distribution System at pre-determined prices
(which is way below the cost of production of the mills). This causes a huge financial burden
on the mills. Levy sugar obligation should be totally abolished and if the Central Government
wants to provide any sugar under the Public Distribution System it should buy such sugar from
the open market and subsidies it from its own resources.
18. Import/Export Policy:
The Government should have a Pro-active Import/Export Policy in order to ensure reasonable
sugar prices so that sustainable cane prices can be paid to the farmers.
19. De-reservation of Cane Area:
Reservation of cane area should be removed. This will help in efficient use of resources, better
farmer-miller relationship and will provide a level playing field. Farmers will also have the
option of supplying their cane to which ever miller he wants.
20. Packing Material:
The Ministry of Textile has been prescribing the minimum percentages from time to time for
compulsory packaging of sugar in jute bags. The packing cost of sugar in jute bags is very high
compared to the other packaging material. The sugar industry is subsidizing jute industries.
The Government should fully exempt the sugar industries from compulsory packaging in jute
bags.
21. Priority Sector:
Sugar industry has been cash striven for decades. Finance is not easily available from
institutions to new sugar factories and to existing factories for expansion as well as for working
capital requirements. Sugar sector being a very important sector in agronomy space should be
classified as a Priority Sector. Besides major issues as above, sugar industry is facing other
issues also as under:
Underutilization of plants installed capacity due to low availability of Sugar Cane
Utilization of sugar cane by Gur / Khandsari industry without any control
Low Recovery
Prices of Ethanol
Sale of Cogen power in open market
REMEDIES ON THE PROBLEMS OF INDIAN SUGAR INDUSTRIES
Some recommendation for improvement of Indian sugar industries in other words this remedies
on the problem of Indian sugar industries point of my view.
progressively reduce the levy sugar commitment of the sugar factories. Even the restrictions
on free sale of sugar can be dispensed with. The fear that the mills would raise the domestic
price through the creations of artificial scarcity is an immaterial one as long as the option of
sugar import with reasonable tariff duties is open to the country. The other fear is that the
industry in its eagerness to sell too much within too short period will push down the domestics
price level is an equally unrealistic one as this a common problem to any industry which it must
manage itself the industry was earlier managing exports very well by spreading the loss across
all units so given an opportunity to manage their supply subject to some broad guild lines and
safeguards (for exp. A buffer stock requirement) which the government can prepared with
adequate homework and stipulate the industry should be in position to handle the matter the
artificial lowering of domestic price of sugar in merely serving the interest of downstream
industries which are bulk consumers of sugar in the free market. Ones these bureaucratic
barriers are removed the industry itself can take more interest in developing its own retails
distribution system. It will also make the management incentive schemes a redundant issue.
Ones again give the government usual apprehensions about switching gradually decreasing the
periodicity of release order Quota.
7) Issue of Industrial sickness:
Although the incidence of inefficient operations and resulting sickness is one average higher
for Co-Operative and public sector units private sector too is not free such problem as the
present study demonstrates.
As the Mahajan Committee and an earlier RBI Committee have suggested either the provisions
BIFR for rehabilitation of stick mills should be intended or an alternative arrangement must be
made without further duly to take care of the problems of sick Co-Operatives however it
appears that there are chronically sick mills in all the three sectors which cannot be rehabilitated
they must be allowed natural death by switching over to a market based system in the
functioning of this industry.
8) Financial Restructuring and meeting credit needs
The sugar industry in India has been in great financial stress since year 2001. It is therefore
essential to understand the factors that have contributed to it.
9) Effect of drought / floods on sugar production Maharashtra is the largest producer of
sugar in the country the Tamilnadu Andhra-Pradesh and Karnataka are some of the other major
producer of sugar this states are of crucial importance to national production of sugar droughts
in 2002- 2003 and 2003-04 and woolly aphid infestation have seriously efficient sugar cane
production in these states it is estimated that the availability of sugar cane was reduce from 165
lack tons in 2002-2003 to 121 lack tons in 2003-2004 in Tamilnadu from 120 lack tons in 20022003 to 86 lack tons in 2003-2004 in Andhra-Pradesh 172 lack tons in 2002-2003 to 100lack
tons in 2003-2004 in Karnataka and from 535 lack tons in 2002-2003 to 290 lack tons in 20032004 in Maharashtra on the other hand because of regular floods sugar cane production in Bihar
has been consistently falling. Since the last 4 years the sugar production in the country as a
result fell from 201 lacks M.T. in 2002-2003 to 140 lacks M.T. in 2003-2004.
Commodity Profile for Sugar
1.0
Sugar Estimates for India (Crop Year: October 2014 to September 2015)
(Unit: Lakh Tonnes)
Source
DoF & PD
DoF & PD
DoC
DoC
DoF & PD
DoF & PD
of Commerce
For preparing estimate for 2014-15 total exports and total imports have been taken as last three
years average.
Production and consumption projected by DoF&PD.
Availability: opening stock in central pool plus production plus Total Imports; Total
Availability for Domestic
Consumption: Availability minus (total export plus ending stock in central pool).
*: The figure of export and import is for October,14 - March, 2015.
#: As per Department of Food figures
^: production projected by Department of Food & Public Distribution for year 2014-15.
2.0 Production, Area under cultivation and Yield of Sugarcane and Sugar
Table 2: Production, Area Under Cultivation and yield of sugarcane and Sugar
Crop/marking Area
Production (Lakh Tonnes) Sugarcane Yield
Year
(lakh Hectares) Sugarcane
(Tonnes/Hectares)
Sugar
42.0
2811.7
193.2
66.92
2005-06
51.5
3555.2
282.0
69.02
2006-07
50.6
3481.9
263.0
68.88
2007-08
44.2
2850.3
146.8
64.55
2008-09
41.7
2923.0
188.0
70.02
2009-10
48.8
3423.8
243.5
70.09
2010-11
50.4
3610.4
263.4
71.67
2011-12
49.99
3412.0
258.5
68.25
2012-13
50.12
3521.4
245.5
69.84
2013-14
N.A.
3549.5#
250.46
N.A.
2014-15
Source: Department of Food & Public Distribution (for Sugar Production) and Agricultural
Statistics (for production and area of Sugarcane).
#: As per 2nd Advance Estimate (2014-15) of DAC released on 18/2/2015
Indias sugar production has increased in last 10 years at CAGR of 6.04 percent.
During the same period, Indias sugarcane production has increased at CAGR of 3.97
percent and area under cultivation at CAGR of 3.19 percent.
Substantial part of Indias sugar imports came from Brazil in 2013. Germany, USA,
Netherland, and Pakistan also exporting sugar to India.
Trade figure shows, that India has been exporting sugar more than that of its import
since 2010-11.
5.0 Prices of Sugar in Bench Mark Domestic Market (Unit: Rs/ Quintal)
Table 7: Prices of Sugar in Bench Mark Domestic Market
6 May,
2015
Week Ago
(29 April,
2015)
Month Ago
(5 April,
2015)
Year Ago
(6 May, 2014)
Sugar: S grade
2523
2523
2498
3248
Erode
2412
2446
2360
3069
Kolhapur
NA
NA
NA
NA
Kolkata
2563
2572
2480
3234
Vashi
Sugar: M Grade
2735
2750
2635
3355
Delhi
2573
2573
2548
3298
Erode
2814
2785
2674
3382
Kanpur
2542
2562
2452
3173
Kolhapur
2779
2840
2695
3395
Kolkata
2695
2719
2628
3308
Muzaffar Nagar
Source: National Commodity & Derivatives Exchange Limited (NCDEX)
% Change
over Previous
Year
-22.32
-21.41
NA
-20.75
-18.48
-21.98
-16.79
-19.89
-18.14
-18.53
Domestic prices of sugar in major markets in April, 2015 were lower compared to
same period in the previous year.
Source: Horner, 2014, Haley & Haley, 2012, Bedi, Bedi, & Sooch, 2013 and
Department of Pharmaceuticals, 2014.
manufacturers accounting for almost 37% of market share (Planning Commission,
2012b).Generic manufacturers dominate the Indian pharmaceutical industry and remain pivotal
in providing essential drugs at affordable prices. Patented drugs, on the other hand, comprise
approximately 1% of the pharmaceutical market in the country (Kochhar, 2014).
2.2 Healthcare in India
Health policy in India has historically centred on the idea of equity. More recently, it has been
broadened to incorporate the subject of universal healthcare. Ironically, despite the focus on
equity, accessibility and quality, India shoulders a high morbidity and mortality burden
(Balarajan et al., 2011) and requires innovative solutions to reduce them.
The State in India intervened directly in the healthcare sector by providing health
services through a chain of public hospitals and Primary Health Centres (PHCs). But a variety
of deficiencies plagued the efficacy of the healthcare system. One of the central drawbacks has
been limited expenditure in the sector (Duggal, 2007; Selvaraj & Karan, 2009). The National
Health Policy, 2002 directed the state to commit to universal health care through a realistic
consideration of capacity (MoHFW, 2002). The policy document identified its limited capacity
(infrastructure and resources) as a key challenge towards making healthcare available to all.
Expenditure on health has remained only about 1% of the GDP in 2011-12 (Planning
Commission, 2012b: p.4). Over the years, the states inability to provide for the health needs
of the population has resulted in the growth of the private healthcare sector. Currently, India is
one of the most privatized systems in the world (Abhiyan, 2012; Duggal, 2007). The states
strategy to withdraw from the public provision of healthcare has been criticized due to the
associated increase on the costs of healthcare (Duggal, 2007; Selvaraj & Karan, 2009).
Moreover, the recent move by the Federal government to reduce the health budget by 16-17%
would imply lower state involvement in the provision of public health (The Economic Times,
2014) and may further increase the cost of healthcare for Indian households unless state
governments who are expected to receive more resources from the Federal government use
these resources in a more innovative and efficacious manner.
Nonetheless, the 12 th five-year plan (2012-17) had outlined universal health coverage
as a central goal proposing an innovative strategy of combining insurance (Rashtriya Swasthya
Bima Yojana), contracting out services and promotion of generic drugs through prescription
drug reforms (Planning Commission, 2013). Such innovative policies are critical for providing
affordable healthcare and reduce the out of pocket expenses on the same. A significant fraction
(72%) of out of pocket expenses on healthcare is incurred on the purchase of drugs and other
medical devices (Kumar et al., 2011). Deregulation of drug prices in recent years had led to an
increase in the prices of branded drugs within the country (Bhargava & Kalantri, 2013) and has
been brought back partially. Consequently, access to affordable medicines remains a critical
issue and any policy or other innovation that can reduce costs would be very useful.
3. Changes in the IP regime and IP Policy Innovations
As mentioned, it is not possible to easily attribute health-related innovations in recent years to
the new TRIPS regime as a variety of other confounding factors are at work. Therefore, we do
not posit any such linkage. This section provides a brief summary of the new IP regime that
highlights the policy innovations that the Indian government has undertaken as a part of the
new regime. Additionally, the section identifies a few IP policy gaps that have surfaced and
need correction.
As discussed, the earlier IP regimes protection of process and not product inventions
resulted in Indian firms focus on process innovation and building of capabilities to produce
bulk drugs in a very cost-effective manner. There is no consensus on the impact of the new IP
regime on the innovation climate in the Indian pharmaceutical industry; while some suggest
that the impact has been positive (Bouet, 2014; Godinho & Ferreira, 2012), others argue that
the impact has been negative or insignificant (Mani, 2014; Chaudhuri, 2007). Still others argue
that while the jury is still out, interesting firm responses in terms of innovation can be seen
(Basant, 2011).
A number of firm-level and state-level strategies have helped the industry to adapt to
the changes in the IP regime. During the pre-TRIPS period the growth of the domestic public
sector and policies relating to science and technology, taxation, and FDI empowered Indian
pharmaceutical industry to adapt to the changes in the institutional environment and grow.
(Agarwal, Gupta & Dayal, 2007). In recent years, the liberalization policies, TRIPS- compliant
patent regime, and other policy support has resulted in a steady flow of inputs to support
product and process innovations: post TRIPS regime has seen an increase in the FDI and
technology transfers directed towards India (Agarwal et al., 2007; Rai, 2008; Chittoor et al.,
2008).
While some critics of the TRIPS compliant IP regime have argued that the new IP
regime would lead to a rise in the prices of drugs and expose domestic manufacturers to the
vagaries of international market fluctuations, others suggest that provisions to protect domestic
consumers and manufacturers are in place (Mani, 2014). These have taken the form of
conditions for compulsory licensing 4 (Section 84) and standards of patentability (Clause
3d1).These provisions attempt to balance the two ideals of ensuring access to medicines and
fostering innovation.
3.1 Policy Innovation to Avoid Evergreening
In the year 2006, Novartis applied to the Indian patent office seeking a patent for its
formulation Glivec. The application was rejected as the IPO viewed the move as an attempt
towards ever greening. Glivec or ImatinibMesylate is a formulation used in the treatment of
blood cancer or Chronic Myeloid Leukaemia (CML) and costs $ 5,000. The cost of the
medication acted as a strong barrier to many Indians who sought treatment. On the other hand,
the generic variant of the drug is available in India for a meagre $200.
Novartis applied for a patent in the year 1998, and in 2005, was granted exclusive
marketing rights and the application was mail boxed for consideration (Chaudhuri, 2014).
The patent application was rejected under clause 3(d) of the Indian Patent Act on the grounds
that the formulation was a modification of the existing drug and does not enhance efficacy
adequately. (Gabble & Kohler, 2014; Chaudhuri, 2014). Post the rejection of the plea in 2006,
Novartis challenged the decision in the Supreme Court of India. The court backed the ruling
and rejected Novartis appeal for a patent in 2013. It has been suggested that since the Indian
patent legislation does not define the term efficacy. Hence, the difference in interpretation
led to the rejection of the appeal (Gabble & Kohler 2014).
On March 4, 2015, using Article 3(d) the Indian Patent Office revoked Boehringer
Ingelheim Pharma GMBH & Co.s patent covering the drug Spiriva in a response to a postgrant opposition filed by the Indian generic drug-maker, Cipla. Interestingly, a pre-grant
opposition was also filed by another domestic firm in 2007 but the patent was granted.2
3.2 Compulsory Licensing
In 2012, Natco Pharma was granted a compulsory license to manufacture generic
variant of the Nexavar drug. Nexavar is the original formulation of Bayer and is used in treating
kidney and liver cancer. The drug costs $ 5500 vis--vis the generic variant that costs $141
(Kochhar, 2014; Hirschler, 2014). Bayer contested the license in the Indian court and lost
(Hirscheler, 2014). The arguments used were that the drug availability did not meet the
reasonable requirements of the public, that it was not reasonably affordable and was not
sufficiently worked in India, not being locally manufactured.
Clause 3d states that the discovery of a variant of an existing substance or process that does not enhance
efficacy significantly is not patentable. The clause attempts to discourage frivolous inventions.
2
http://ipindiaservices.gov.in/decision/00558-DELNP-2003-9637/558-delnp-2003%2025(2)%20decision.pdf
Clause 13(4) states that granting of a patent does not necessarily translate into validity of the
patent.
4
In the February, 2005, Troika pharmaceuticals filed for a patent for its invention: the 75ml
Diclofenac Injection, an anti-inflammatory drug. In the following years other companies filed
for patent applications presenting a formulation similar to that of Diclofenac injection.
provides a strong case, suggesting that Section 13 (4) can be dysfunctional. Notably the courts
in the US and Europe treat the patent valid and thereby curb frivolous challenges and facilitate
quick infringement action.
4. Innovations in the Indian Pharmaceutical Industry
This section discusses technology innovations and strategic responses by pharmaceutical firms
including changes in R&D expenditures and organizational innovations. Studies show that
organization level changes have backed the institutional change introduced in the form of a
changed patent regime. While Kale & Wield (2008) argue that the new regime has provided
India with the opportunity to exploit its advantage at reverse engineering and explore the
area of enhanced R&D in medical innovation, Haley & Haley (2012) suggest that the Indian
pharmaceutical industry has been adversely affected by the policy change.
4.1 Manufacturing Capability and ANDA Approvals
The dominant perspective, however, is that given the focus on process innovation during the
pre-TRIPS period , India acquired a competitive advantage in the production of quality bulk
drugs (Chittoor et al., 2008). This initial strength in imitative capabilities provided a fertile
ground to develop innovative capacities with changes in technology and policy (Kale &
Little, 2007). Consequently, the number of FDA approvals obtained by Indian pharmaceuticals
has greatly increased. Exploiting this opportunity with better production processes, India is
currently one of the leading generic drugs manufacturers. In fact, India manufactures eight out
of the ten blockbuster drugs (Agarwal et al., 2007). The process innovation driven building
of manufacturing capabilities, fostered by the pre-TRIPS regime, has helped Indian
pharmaceutical firms capture a significant share of ANDA approvals in the US. In recent years,
Indias share has been more than 40 per cent (Fig. 2) despite the increasing cost of compliance.
4.2 Trends in Patenting Activity
The post-TRIPS regime has witnessed greater investment in R&D (Jagdeesh and Sasidharan,
2014). A detailed econometric exercise has shown a shift to a stronger IP regime has resulted
in greater thrust in the R&D activity in the sector (see some estimates below) and domestic
firms have also increased patenting in India and abroad (Goldar et al, 2010). Within
Additionally, the grant process was delayed due to the procedural hurdles in the form of
measures for pre grant and post grant oppositions.
pharmaceutical R&D, there has been a significant increase in the focus on novel drug discovery
(Agarwal et al., 2007), although new dosage forms remain dominant among product patents.
The data on PCT applications (Figure 1) suggests that in anticipation of the change in the IP
regime in India in 2005, the top Indian pharmaceutical firms showed an increase in inventive
activity. In the subsequent period there has been a trend decline in PCT applications by these
pharmaceutical firms. Although, the reasons for this decline are not very clear, studies had
observed a global downtrend in the patent applications during the crisis period in the late 2000s
and beyond.
The patent filing activity in the Indian Patent Office has increased dramatically in recent years
(Table 1). Overall, the top pharmaceutical firms seem to have engaged significantly more in
inventive activity in the post-TRIPS period. A comparison of the patenting activity of the top
eleven large pharmaceutical companies during the period 1999 - 2009 has brought out some
interesting patterns (Bedi, Bedi and Sooch, 2013). During 1999 - 2004, when product patents
in pharmaceuticals were not permitted, a much larger share of applications related to inventions
in the field of new/improved processes t o m a k e products than for the products themselves
(Figure 2). There has been an increase in the product patent applications filed by large
Indian pharmaceuticals companies after 2005 (Figure 3). The product related applications
include intermediates and formulations with maximum contribution from modified release
dosage forms. Besides, most top companies are increasingly using the PCT route for filing
patent applications. (Bedi, Bedi and Sooch, 2013). Patenting by SMEs in the sector is, however,
small although as we shall see below patenting is widely prevalent among start-ups in this
sector.
Table 1: Status of Patents Filed at the Indian Patent Office
Patent
2002-03
2005-06
2009-10
Filed
11466
24505
34287
2012-13
43674
Granted
1379
4320
6168
4126
Source: Compiled from Controller General of Patents, Designs, Trademarks, Annual Reports
2005-06, 2009-10 & 2012-13
Apart from New Drug Discovery a number of firms are also participating in Novel Drug
Delivery Systems (NDDS). Firms like Ranbaxy, Alembic and Dabur have been able to produce
NDDS formulations with great success and have as a result also entered into licensing
agreements with foreign players (Joseph, 2012). In an earlier study, it was shown that while
few pharmaceutical and biotech firms in India patent in the US, a significant proportion
(ranging from 48-59% depending on the estimates used) of these firms have product claims.
However, most (about 55%) of these applications are for incremental inventions including
those relating to bio-enhancers, new dosage forms, new use and NDDS (Basant, 2011). In
vaccine development, Rotavac Vaccine presents a salient example of indigenous innovation.
Rotavirus diarrhoea is a major cause of death amongst several children from poor socioeconomic backgrounds. Estimates suggest that rotavirus accounts for 37% of diarrhea related
deaths globally and 22% of diarrhoea related deaths amongst the under-five age group in India
(Bhaumik, 2013; N. Mehta, 2015). Pioneered by Indian pharmaceutical company, Bharat
Biotech, the three dosage vaccine displayed 56% higher efficacy and is available at a fraction
of the current cost. This provides an example of tropical and other diseases where the
magnitude presents a profitable opportunity to innovate and achieve economies of scale and
low cost solutions.
Despite the evidence of higher inventive activity, studies in the domain of biotechnology
provide divergent perspectives; while some argue
that the changed patent regime has
benefitted in the take-off of the knowledge intensive sector (Agarwal et al., 2007), others
suggest that it may not have contributed at all (Ramani & Maria, 2005). But all the studies
reviewed make a case for the immense potential the sector holds in delivering for the medical
needs of the future. The writings recommend focus on off-patent products such as biogenerics, vaccines and diagnostics arguing that reengineering is the true edge required for
establishing Indian biotech competence on an international stage (Ramani & Maria, 2005).
Besides, given the decentralization of drug development process, Indian firms are finding
niches to become part of the international R&D networks. (Basant, 2011)
4.3 Entrepreneurial Innovation
High penetration of mobile phones and the Internet in India has fostered a variety of
innovative medical devices and healthcare solutions. Many of these have been introduced
through start-ups as these increasingly provide profitable business opportunities and also have
a social impact by enhancing healthcare access. Many of these innovations currently lie outside
the ambit of TRIPS and once scalable, the products hold great potential to address a variety of
public health concerns.
While there is a fair bit of entrepreneurial activity in the healthcare provision, many IP
based biomedical start-ups have also been set-up in recent years. Unfortunately, there is no
systematic database of such start-ups. A recent survey of 50 such companies has brought out
two very interesting features5:
a. There is a fair bit of diversity among these IP based biomedical start-ups. Firms provide
diagnostics products, biologics & services, medical devices, small molecule drug
discovery, chemistry based or other drug discovery services and software based
services; and
b. Almost all (44 out of 50) either have some sort of IP or plan to have it in future. More
than 50% (27) of these firms have either filed for patents or have patents issued in their
name and an additional 20% (10) plan to file for patents. Interestingly, apart from
protecting their technologies from imitation, patenting is used by them to attract venture
capital, enhance reputation and improve their bargaining power in inter-firm deals.
Innovation possibilities in medical devices seem quite high. Available estimates suggest
that the market size of this sector is about
2012a) and is growing at the rate of 16% annually (Pulakkat, 2014). About 75% of the
medical devices available in India are imported (Jaroslawski & Saberwal, 2013).
Entrepreneurship in this arena has targeted low-cost innovative solutions but in the absence
of the required resources (infrastructure, capital, and technical know-how), innovations in
non-drug based products remains gravely underinvested.
Broadly, innovative entrepreneurial solutions in healthcare have taken three forms; replacing,
supplementing and enabling the public sector or established private sector endeavours in this
space. Replacement aims to occupy the space inadequately covered by the public/private
sector; Aravind Eye Care that aims to target eye illnesses and blindness in cost effective
manner, is an example. Similarly, emerging telemedicine based solutions like eVaiday can
replace several health care initiatives. (https://www.evaidya.com/home.html#!/home)
Several new devices can supplement the services that are currently being provided by existing
healthcare systems or be enablers to make them more efficacious by supporting the paramedics,
frontline health workers and PHCs with technology. The innovation of Swasthya Slate6 (Health
Tablet) is a prime example that facilitates decentralized diagnosis. Similarly, a diagnostic
equipment, 3Nethra developed by a start-up, Forus is revolutionising remote decentralized
screening of a variety of eye ailments (http://forushealth.com/forus/). In the same vein,
innovations
such
as
Bio
sense
(http://www.biosense.com/)
and
Achira
These observations are based on a personal communication from Dr Gayatri Saberwal who
has undertaken this survey.
6
(http://www.achiralabs.com/) are easy to manoeuvre diagnostic devices that aim to take testing
and diagnostic services to each household. While one innovation assists in non-invasive
haemoglobin level testing, the other is dependent upon micro fluids to diagnose the ailment.
Innovations such as a Windmill (http://windmillhealth.weebly.com/neobreathe.html) and
Embrace (http://www.embraceinnovations.com/) address the issue of infant mortality. Other
innovations include low-cost sanitary napkins7 , devices to monitor cardiac health8 12, low cost
health products (insulin) 9 etc.
Given the healthcare needs of the nation, such innovations have thus far targeted affordability
and ease of use. A critical challenge to popularizing the technologies is the cumbersome and
expensive process of accessing administrative approvals (Jaroslawski & Saberwal, 2013).
4.4 Strategic Responses and Innovations
Kale (2010) suggested that the new patent regime has led to organizational learning to provide
strategic response to the changed situation. The learning has been both internal, focused
towards developing stronger processes and external, whereby firms collaborate with foreign
partners.
Indian
firms have
employed
alternative strategies
that focus on
greater
internationalization which has taken two forms: facilitating greater inflow of FDI and
entering into joint ventures and acquisitions abroad. Kale and Weild (2008) divide Indian
pharmaceutical firms into three categories: alpha, beta and gamma. Alpha firms invest in
foreign subsidiaries; beta firms enter into joint ventures with foreign partners to leverage the
existing capacities in biotechnology capabilities and gamma firms acquire foreign firms.
Between, 1999-2004, the number of joint ventures rose from 7 to 20, and wholly owned
subsidiaries grew from 4 to 52 (Agarwal et al., 2007). International JVs and acquisitions have
focused on accessing marketing, manufacturing and R&D capabilities. Besides, the trend
towards joint ventures and acquisitions indicates a higher risk appetite.
Arguably, two
institutional changes had a noteworthy impact on the number of mergers and acquisition
undertaken by Indian pharmaceutical and drug industry; the liberalization policies undertaken
7
since 1991 and the changes in the IP regime post TRIPS. (Mishra and Chandra, 2010) There
has also been significant consolidation within the Indian pharmaceutical industry with a lot of
M&A activity suggesting the need of large size to compete effectively in the new business
environment. (Table 2)
Table 2: Mergers and Acquisitions in Indian Pharmaceutical Industry
M&A-Completed Deals
Announced Total Value (US mil. $)
Year
15
2005
7
2006
9
2007
9
2008
5
2009
12
2010
7
2011
11
2012
9
2013
7
2014
Source: Compiled from Prowess Database
39.6
24.8
605.8
2336.8
197.6
3809.2
241.9
199.8
1859.7
406.1
Overall, the trend seems to be that Indian firms, at least the larger ones, are adopting strategies
to remain competitive in this knowledge intensive sector with a sharp focus on building
technological capabilities (Basant, 2011). Chittoor et al. (2008) argue that the Indian
pharmaceutical industry has adapted to greater indigenous growth and entry of MNCs. Besides,
in order to make up for the late-mover disadvantage, Indian firms have acquired absorptive
capacities and have begun importing technology and other inputs.
(Chittoor et al.,
2.7
4
5.3
7.4
10.2
16.3
22.8
30.3
38.6
41.2
49.7
58.2
68.7
75.5
87.2
107.3
0.13
0.13
0.15
0.05
0.06
0.05
0.04
0.05
0.04
0.07
0.07
0.08
0.06
0.04
0.04
0.05
0.91
1.18
1.55
1.96
2.21
3.04
3.99
4.59
4.66
4.31
4.41
4.51
4.67
4.63
5.13
5.85
provisioning
seen as
with
as increasing number of
pharmaceutical firms would be oriented towards lucrative Western markets with nations like
India becoming the pharmacy of the developed world.
Other factors that contribute to rising prices are: marketing practices adopted by
pharmaceuticals that lead to increased cost of treatment and weakening of the drug price control
order. The unholy nexus between doctors and pharmaceuticals may also reduce access to
healthcare. Marketing practices employed by several pharmaceutical companies aim to
influence doctors to prescribe drugs by certain companies (Mehta, 2015; Kalaskar & Sagar,
2012). The high cost of prescribed drugs and diagnostic services escalates the costs associated
with treatment and might even deter several households from seeking treatment for ailments.
DPCO that came into force in 1970 was instrumental in controlling the price of essential
drugs. The DPCO has the authority to monitor the prices of the drugs listed under the National
List of Essential Medicines. The price regulation is carried out by the National Pharma Pricing
Authority (NPPA). The DPCO monitored the prices of 75 drugs in 1995 and by 2002 only
30 drugs remained under price control. The argument supporting the trend maintains that due
to rising competition in the Indian drug market, the drugs were already priced very low and
hence were affordable (Chittoor et al., 2008). While others argue that more drugs should be
included under price control and in the essential drug list that have reference prices based on
the lowest price alternative (Selvaraj et al., 2012). In a policy reversal in 2013, DPCO brought
348 essential drugs within its purview (Department of Pharmaceuticals, 2014). The
intervention is aimed towards controlling the expenditure incurred upon medical bills and
demolish cost barrier to access healthcare.
Recognising the importance of keeping the drug prices affordable in the current context of the
liberalized economy and the new IP regime, a few policy changes seem noteworthy:
a. The recent legislation- Uniform Code of Pharmaceutical Marketing Practices (UCPMP)
- aims to control for the unethical and unwanted prescriptions and to ensure access to
health for all. The legislation is currently voluntary in nature and mandates doctors to
prescribe generic brand names. The current legislation is not a new development but is
another effort to control the unethical practices and alliance between Pharmaceutical
companies and doctors.
b. Introduced in the year 2008, Jan Aushadi scheme aims at making low-cost and quality
generic drugs available for sale to the general populations. The ambitious project took
off from the state of Punjab in Amritsar and at present 40 such stores have come up.
generic drugs (Lalitha, 2008; Nautiyal, 2015). Additional state based inititatve such as
mobile medical units (http://healthmarketinnovations.org/program/deen-dayal-chalitaspatal-mobile-units; http://healthmarketinnovations.org/program/arogya-rath-mobilemedical-units-mmu-bihar) in Bihar and Madhya Pradesh offer the communites located
in difficult and remote topographies greater access to healthcare.
4.4.2 The scheme has been implemented in hilly & backward areas and also in the districts,
which had received less than `50 lakh for dairy development activities under Operation Flood
programme. The projects are implemented by the State Cooperative Milk Federations/ District
Cooperative Milk Unions in view of their expertise & professionalism and the funds under the
revised scheme are released directly to the implementing agencies. There is no discrimination
of gender and class under the scheme. (The scheme has been subsumed under the new scheme
titled National Programme for Bovine Breeding and Dairy Development approved on
19.12.2013).
4.4.3 Since inception of the scheme, 114 projects have been approved. Out of these, 60 projects
are under implementation and 54 projects have been completed. 261 districts have been
covered in 27 States and a UT with a total cost of `716.40 crore upto 31.03.2014, including
four projects for Special Livestock Sector and Fisheries Package for the Suicide Prone
Districts in the States of Andhra Pradesh, Maharashtra, Karnataka and Kerala. A total sum of
`577.88 crore has been released to the concerned state govt and Milk Union/Federations for
implementation of projects up to 31.03.2014. These projects have benefited about 27.90 lakh
farmers in 38,817 villages in various States procuring over 38.91 lakh kgs of milk per day and
marketing milk of about 28.12 lakh litres per day. Milk chilling capacity of 34.38 lakh litres
per day and milk processing capacity of 42.90 lakh litres per day has been created under this
scheme.
4.5 Assistance to Cooperatives
4.5.1 Assistance to cooperative Scheme was launched as Central Sector Scheme in January,
2000 with the objective to rehabilitate the sick dairy cooperatives. It provides grants in aid on
50:50 sharing basis between Central and the State Government to loss making Milk Unions. It
has been implemented by NDDB and the revival plans of the sick Milk Unions are prepared
by NDDB in consultation with the concerned Milk Union. The rehabilitation plan is prepared
in such a manner that the net worth of the sick cooperative will become positive within a period
of seven years from the date of approval. (The scheme has been subsumed under the new
scheme titled National Programme for Bovine Breeding and Dairy Development approved
on 19.12.2013).
4.5.2 Since inception of the scheme, the rehabilitation plans for 42 Milk Unions have been
approved at the total cost of `289.64 crore with 50% Central share of `144.81 crore. Out of it,
an amount of `127.66 crore as Central share has been released under the scheme upto 31th
March, 2014. As on March, 2013, the rehabilitation period of seven years is over with respect
to 27 milk unions, out of these, 8 milk unions have achieved positive net worth while 6 milk
unions are earning profits but have not yet achieved positive net worth. 13 Milk Unions
continue to incur losses and have negative net worth. Of the remaining 15 Milk Unions, 11 are
likely to achieve positive net worth before completion of the rehabilitation period of seven
years.
members have been trained, 2,271 Bulk Milk Coolers (BMCs) with a total milk chilling
capacity of 47.47 lakh litres installed and 1,796 existing laboratories have been strengthened.
4.7 Dairy Entrepreneurship Development Scheme
4.7.1 Dairy Entrepreneurship Development Scheme (DEDS) was launched in September, 2010
with the objective for promotion of private investment in dairy sector in order to increase the
Milk Production in the country and helping in poverty reduction through self-employment
opportunities. This scheme is being implemented through NABARD which provides financial
assistance to commercially bankable projects with loans from Commercial, Cooperative, Urban
and Rural banks with a back ended capital subsidy of 25% of the project cost to the
beneficiaries of general category and 33.33% of the project cost to SC & ST beneficiaries. The
cabinet Committee of Economic Affairs (CCEA) in its meeting held on 12.12.2013 has
approved for continuation of the scheme with certain modifications and the budget provision
of `1,400 crore during 12th Plan.
4.7.2 Since inception, against the total release of `724.70 crore, NABARD has disbursed
`677.05 crore as back ended capital subsidy to the beneficiaries for setting up of 1,86,325 dairy
units upto 31st March, 2014.
4.8 National Programme for Bovine Breeding and Dairy Development (NPBB&DD)
4.8.1 After merger of four ongoing schemes namely Integrated Dairy Development Programme
(IDDP), Strengthening Infrastructure for Quality & Clean Milk Production (SIQ-CMP),
Assistant to Cooperatives (A to C) and National Project for Cattle & Buffalo Breeding
(NPCBB), a new Scheme titled National Programme for Bovine Breeding and Dairy
Development (NPBB&DD) has been launched on 27.02.2014. NPBB&DD has been provided
budgetary provision of `1,800 crore for implementation during 12th Five Year Plan.
NPBB&DD will have two components (a) National Programme for Bovine Breeding (NPBB)
and (b) National Programme for Dairy Development (NPDD). The Scheme has following
objectives:
4.8.2 National Programme for Bovine Breeding:
(a) To arrange quality Artificial Insemination services at farmers doorstep
(b) To bring all breedable females under organized breeding through Artificial Insemination
or natural service using germplasm of high genetic merits
(c) To conserve, develop and proliferate selected indigenous bovine breeds of high socioeconomic importance
(d) To provide quality breeding inputs in breeding tracts of important indigenous breeds so as
to prevent the breeds from deterioration and extinction
4.8.3 National Programme for Dairy Development:
(a) To create and strengthen infrastructure for production of quality milk including cold chain
infrastructure linking the farmer to the consumer
(b) To create and strengthen infrastructure for procurement, processing and marketing of milk
(c) To create training infrastructure for training of dairy farmers
To help increase productivity of milch animals and thereby increase milk production to
meet the rapidly growing demand for milk
To help provide rural milk producers with greater access to the organized milk
processing sector
4.9.1.3 All the 14 major dairying states which are focus area of NDP-I and Uttarakhand have
complied/committed to a timeline for compliance to undertake key policy/regulatory measures
to create an enabling environment for successful implementation of NDP-I.
4.9.1.4 Till March, 2014, 171 sub project proposals (SPPs) have been approved with a total
outlay of `1,146.63 crore which includes nine projects of Project Management and Learning.
Out of the total approvals, `991.90 crore would be grant assistance and `154.73 crore would be
contributed by the EIAs.
4.9.1.5 The Department of Animal Husbandry, Dairying and Fisheries (DADF) has released
`266.79 crore for NDP-I till March, 2014, of which `139.79 crore was received during 201314. Till March, 2014, `204.55 crore has been released to EIAs for implementation of the sub
projects and undertaking Project Management and Learning activities.
4.9.2 Animal Breeding Activities
4.9.2.1 To meet the demand for disease free HGM bulls of different breeds for production of
high quality disease free semen doses, Progeny Testing (PT) and Pedigree Selection (PS)
programmes are being implemented under NDP-I. These programmes aim to produce/meet the
entire requirement of HGM bulls for frozen semen stations across the country by the end of the
project period. Existing semen stations are also being strengthened to produce high quality
disease free frozen semen doses.
4.9.2.2 Under PT programme, 13 sub projects from 10 states have been approved which are
expected to make available more than 2,000 bulls to semen stations across the country.
4.9.2.3 For conservation of indigenous breeds of cattle and buffalo, six sub projects from four
states have been approved for bull production through PS. These sub projects are expected to
make available about 360 bulls to semen stations across the country.
4.9.2.4 Nineteen sub projects for strengthening of semen stations have been approved from 12
states. These semen stations together are expected to produce more than 85 million doses per
annum by the end of the project.
4.9.2.5 Two sub projects for undertaking pilot model for viable doorstep AI delivery service
has been approved wherein 4,868 villages would be covered by 730 Mobile AI technicians. A
proposal to import 2,400 embryos of HF and Jersey has also been approved.
4.9.3 Animal Nutrition Activities
4.9.3.1 To ensure that milch animals produce milk commensurate with their genetic potential,
Ration Balancing Programme (RBP) and Fodder Development Programme (FDP) are being
implemented. Under RBP least cost balanced ration is formulated at the farmers door step by
the local resource person (LRP) using user-friendly software called Information Network for
Animal Productivity and Health (INAPH), developed by NDDB using locally available feed
resources. Under fodder development, field demonstrations of mowers, biomass bunkers,
silage making are being undertaken along with promotion of certified/truthfully labelled fodder
seeds.
4.9.3.2 Under RBP, 34 sub projects have been approved covering 12 states in which about 11
lakh milch animals in 14,000 villages would be covered by LRPs.
4.9.3.3 Twenty nine sub projects, approved under FDP spread across 12 states, provide support
for setting up five new seed processing plants, one crop residue enrichment and densification
plant, 985 demonstrations for silage making, 318 demonstrations for use of mowers and 60
demonstrations for use of bio-mass bunkers.
4.9.4 Village Based Milk Procurement System
4.9.4.1 To expand coverage/enable milk producers have greater market access, village level
infrastructure for milk collection are being provided to ensure collection of milk in a fair and
transparent manner including support for Bulk Milk Cooler, Data Processor Based Milk
Collection Unit, Automated Milk Collection Unit, Milk Cans, Milk Collection Accessories etc.
4.9.4.2 The approved 58 sub projects spread over 12 states are expected to cover more than
18,000 villages. About 5.4 lakh new members are expected to be enrolled in these sub projects.
4.9.5 Training and Capacity Building
4.9.5.1 Various training and capacity building programmes have been organized for farmers,
field functionaries and EIA personnel to upgrade the knowledge base and the skill sets required
for the successful implementation of the sub projects. It is expected that during the project
period about 20 lakh participants would be trained/oriented under NDP-I. These training
programmes are being organized either by NDDB or by EIAs.
4.9.6 Environment and Social Management
4.9.6.1 The project also focuses on inclusion of women, Scheduled Castes, Scheduled Tribes
and small holders across beneficiaries and functionaries. During preparation of the sub projects,
necessary consultations and disclosures are being carried out to identify environment and social
issues and mechanisms for its enhancement/mitigation.
4.10 Post Operation Flood and Consolidation of Cooperative Movement by NDDB
4.10.1 The National Dairy Development Board (NDDB), set up in 1965, has its headquarters
at Anand (Gujarat). NDDB was declared an institution of national importance and a statutory
body in 1987. NDDB promotes plans and organizes programmes for the development of dairy
and other agriculture based and allied industries along cooperative lines and also provides
assistance in the implementation of such programmes.
stands revised to `1,952 crore, of which NDDBs financial assistance is to the extent of `1,479
crore.
4.10.3 Animal Breeding
4.10.3.1 Subsequent to the launch of NDP-I in April, 2012, a number of EIAs submitted SPPs
to Project Management Unit (PMU) of NDP-I for production of HGM bulls of various cattle
and buffalo breeds through PT and PS and for strengthening of their Frozen Semen Stations
(FSSs).
4.10.3.2 Till date, 13 PT projects for production of HGM bulls of different breeds have been
approved.
4.10.3.3 SPPs for development and conservation of Indigenous breeds of cattle and buffaloes
through PS of different breeds namely, Kankrej, Hariana, Rathi and Gir breeds of cattle and
Jaffarabadi and Pandharpuri breeds of buffalo which have been approved would be
implemented by Banaskantha Milk Union, HLDB, URMUL Trust, SAG and Maharashtra
Livestock Development Board (MLDB).
4.10.3.4 To meet the growing demand of quality frozen semen for providing quality AI
services, projects for strengthening of 19 A and B graded semen stations have been approved.
4.10.3.5 To meet the urgent need of bulls of exotic breeds, viz. Jersey and Holstein Friesian by
various semen stations, it is proposed to import bulls and embryos for production of breeding
bulls. Four participating agencies have been identified for production of bull calves from these
embryos. International Competitive Bidding procedures have been initiated for import of bulls.
4.10.3.6 Sabarmati Ashram Gaushala, Bidaj, Animal Breeding Centre, Salon and Rohtak
semen stations managed by NDDB Dairy Services (NDS) together produced about 191 lakh
doses of frozen semen during the financial year up to 31st March, 2014. During the same period,
the eight dairy cooperative semen production stations in the country produced another 141.7
lakh frozen semen doses (provisional).
4.10.3.7 NDDB organized a workshop where national and international experts shared their
experiences in implementing breeding programmes in their respective countries. NDDB also
organized a trainers training programme on typing of cattle and buffaloes for functional traits
to provide exposure to coordinators of PT projects on body typing of animals.
4.10.4 Animal Nutrition & Feed Technology
4.10.4.1 Promotion of bypass protein & fat supplements, area specific mineral mixtures and
calf starter continued during the year. Two more mineral mixture plants, each of 12 tonnes per
day capacity, were set up in Shahabad milk union in Bihar and Sabarkantha milk union in
Gujarat. During the year, one bypass protein plant of 50 tonnes per day capacity was also set
up in Patna, Bihar for production of bypass protein supplement.
4.10.4.2 NDDB has formulated a supplement to reduce the incidence of mastitis, which when
fed daily, four weeks prior to calving, to high yielding crossbred cows with a history of clinical
and sub-clinical mastitis in the previous lactation, resulted in reduction of mastitis in these cows
by 80 per cent, as confirmed by Mastect and California Mastitis Tests.
4.10.4.3 NDDB continued its field studies in various regions to evaluate the impact of feeding
a nutritionally balanced ration on enteric methane emission, milk production and metabolic
profile in lactating cows and buffaloes. Feeding a nutritionally balanced ration reduced
methane emission (gm per kg of milk yield) by 19 and 13 per cent in cows and buffaloes,
respectively.
4.10.4.4 Dairy cooperatives were assisted to produce about 5,340 tonnes of certified/truthfully
labeled fodder seeds of maize, sorghum, berseem, lucerne, oats, cowpea, pearl millet and
cluster bean for enhancing green fodder production. About 9.63 tonnes of breeder seeds of
improved high yielding varieties of fodder crops were arranged by NDDB from Indian Council
of Agricultural Research for dairy cooperatives.
4.10.5 Animal Health
4.10.5.1 NDDB has initiated a field pilot project on brucellosis control to create awareness on
the disease and the control measures to be adopted by the farmers in suspect cases of
brucellosis. The main components of the project are: (i) calf hood vaccination of female calves
(ii) identification of vaccinated calves through ear-tagging, (iii) sero-monitoring (iv) Milk Ring
Test (MRT) to identify positive villages, and (v) Rose Bengal Plate Test (RBPT) and ELISA
to identify individual positive animals.
4.10.5.2 The programme is for a period of five years with a total outlay of `169.06 lakh with
NDDB contributing `104.95 lakh.
4.10.5.3 Till March, 2014, 4,429 cattle and buffalo calves between 4 to 8 months of age have
been vaccinated since the commencement of the programme in April, 2013. Data relating to
each vaccinated animal has been captured in INAPH system.
4.10.6 Research and Development
4.10.6.1 Usefulness of FTA card for safe transport of clinical samples from field to the
laboratory is being investigated for diagnosis of brucellosis by real-time PCR. Among various
types of clinical samples genus Brucella could be identified most frequently from milk samples
when spotted on FTA cards.
4.10.6.2 Bovine Genital Campylobacteriosis (BGC) is caused by Campylobacter fetus
venerealis (CFV) and Campylobacter fetus fetus (CFF). A laboratory protocol for cultural
identification of BGC has been standardized. A real-time PCR has also been designed, which
detected DNA from reference strains of CFF and CFV. The assay is under further evaluation
for detecting the organism in clinical specimens.
4.10.6.3 To support diagnosis of Bluetongue (BTV) infection in cattle, a nested RT-PCR
targeting the highly conserved NS1 gene of the virus has been standardized on the lines of the
OIE protocol. The test has been validated with five serotypes of BTV (Serotypes 1, 2, 10, 16
and 23) and with a positive plasmid construct harboring the target gene (NS1).
4.10.6.4 A Loop-mediated isothermal amplification (LAMP) assay for detection of Infectious
bovine rhinotracheitis virus (BHV-1) from bovine semen is being validated targeting gB and
gC gene of the virus which can detect the virus in the semen of IBR sero-positive bulls.
Sensitivity and specificity of the assay is under evaluation.
4.10.6.5 The laboratory continued to provide diagnosis for bovine brucellosis, bovine
tuberculosis, paratuberculosis, IBR and BGC. Screening of extended bovine semen from IBR
sero-positive bulls for BHV-1 by real-time PCR has also been regularly undertaken.
4.10.7 Quality Assurance
4.10.7.1 NDDB assists dairy cooperatives and producer institutions through suitable
technological and capacity building interventions for improving their operations aimed at
ensuring quality and food safety of milk and milk products.
4.10.7.2 NDDB also participates in the development process of appropriate food regulations
and other regulatory matters relevant to dairy sector at the national and international level.
4.10.8 Milk Procurement and Marketing
4.10.8.1 During 2013-14, the average milk procurement by dairy cooperatives was about 344
lakh kg per day (provisional) as compared to about 335 lakh kg per day during the same period
last year, registering an increase of 2.6 per cent. During the same period, the cooperatives
marketed an average of about 247 lakh litres of milk per day (provisional) as against about 238
lakh litres per day, registering a rise of about 3.8 per cent over the corresponding period last
year.
4.10.9 New Generation Cooperatives (NGC) initiatives
4.10.9.1 The two producer Companies namely Paayas and Maahi, incorporated last year,
collectively operate in around 3,000 villages and procure on an average more than 9 lakh kg
per day from about one lakh members out of which 15 percent are women members and 54
percent are small holder milk producer members. Together they a have paid up share capital of
about `32 crore subscribed by their members and are likely to have a combined turnover of
about `1,300 crore for 2013-14.
They have also initiated supply of cattle feed & area specific mineral mixture to the milk
producers.
4.10.9.2 NGC operations continue in Andhra Pradesh, Uttar Pradesh and Punjab. Collectively,
they are procuring about 8 lakh litres per day from 1.4 lakh milk producers spread across about
4,500 villages.
4.11 Details of funds allocated and utilized under Dairy Development Schemes
Sr. No.
11 th plan
12th plan (for Year 2012-13)
12th plan (for Year 2013-14)
capacity of 1,844 TLPD has been created against the target of 1,750 TLPD during the year
2013-14 in Cooperative dairy sector.
4.13 Deficit Monsoon and its Impact on Dairying
4.13.1 The impact of deficit monsoon on livestock sector will be manifested in many forms,
such as: scarcity of crop residues and other feed ingredients because of reduced crop production
and increasing crop failure; decline in reproductive efficiency; increase in incidences of animal
diseases particularly viral and protozoan in animals in milk and decline in milk production.
Reproductive efficiency among breedable bovines decline substantially due to deficiency of
green fodder and quality concentrates. The decline in milk production and reproductive
efficiency will be highest in crossbred cattle followed by buffaloes.
4.14 Milk Situation in the Country
4.14.1 Price trend
4.14.1.1 The yearly inflation rate of milk (base year 2004-05=100) as on March, 2014 was
9.47% as against 4.42% in the previous year. Most State Milk Federations and Metro Dairies
have increased the procurement and selling price of milk over the last one year and the average
increase is about `4.02 per litre and `3.73 per litre respectively. The increase in price is
attributed to the increase in input cost of milk production.
4.14.2 Steps taken to increase availability of milk in the country
4.14.2.1 The measures taken in relation to milk during last two years are as under:
i) Ministry of Commerce vide its notification No.31 (RE2012)/2009-2014, dated 04.02.2013
has exempted the export of processed and/or value added agricultural products from any
restriction/ ban even in the event of restriction/ ban on the export of basic farm produce
including milk products viz. casein & casein products (HS code 3501), butter and other fat
derivatives from milk, dairy spread etc. (HS 0405) and Cheese & curd (HS Code 0406)
ii) Department of Revenue vide its Notification No.30/2013-Customs, dated 21.05.2013 had
decided to continue the waiver on import of oil meals
iii) Department is regularly monitoring the milk situation in the country through review
meetings held bi-monthly
4.15 Delhi Milk Scheme (DMS)
4.15.1 Delhi Milk Scheme (DMS) was set up in 1959 with the primary objective of supplying
wholesome milk to the citizens of Delhi at reasonable prices as well as for providing
remunerative prices to milk producers. The initial installed capacity of Delhi Milk Scheme was
for processing /packing of 2.55 lakh litres of milk per day. However in order to meet increasing
demand for milk in the city, the capacity was expanded in phases to the level of 5.00 lakh litres
of milk per day. The Department has developed a web site http://dms.gov.in for use by related
users.
4.15.2 I.S.O.22000-2005 & I.S.O.14001-2004 - Certification
4.15.2.1 DMS has been awarded ISO 22000-2005 Certification (Raw milk procurement,
processing, packaging, storage & distribution of liquid milk and milk products) valid up to
05.05.2015 and ISO 14001 - 2004 certification (Environmental Management System) valid up
to 30.03.2016 by M/s IRQS, Mumbai.
4.15.3 Procurement of Milk
4.15.3.1 Delhi Milk Scheme has been procuring raw/fresh milk from the State Dairy
Federations of the neighbouring States of Punjab, Haryana, U.P. Rajasthan and Bihar and from
the Co-operative Societies/ Producers Companies & other companies. The details of Milk
procured by DMS from 2010-11 to 2013-14 is indicated below:
Year
2010-11
2011-12
2012-13
2013-14
Average/per day
2.17
2.38
2.95
1.33
Capacity
Utilization (%)
73.10
65.20
62.00
60.20
54.00
Milk Sale
(lakh litres)
1,332.77
1,183.49
1123.62
1096.92
973.28
Variable cost
(` per litre)
19.86
21.75
27.08
25.52
30.70
Fixed cost
(`per litre)
3.05
3.24
3.40
3.60
4.25
Total cost
(` per litre)
22.91
24.99
30.48
29.12
34.95
Husbandry, Dairying and Fisheries. Sale proceeds of milk and milk products are credited to the
revenue account of the Government.
4.15.6.2 The details of funds allocated and expenditure incurred during 2012-13 and 2013-14
are given below:
Head / Scheme
I. NON-PLAN
II. PLAN
(including Civil/
B.E.
R.E.
370
2.00
366.64
2.00
2012-13
Expenditure incurred
340.83
1.56
B.E.
451.05
10.00
2013-14
R.E.
Expenditure
incurred(Prov.)
371.40
323.35
3.65
2.70